C-reactive protein as a biomarker for urological cancers.
about
C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot studyLow vitamin D status is associated with inflammation in patients with prostate cancerC-reactive protein in patients with advanced metastatic renal cell carcinoma: usefulness in identifying patients most likely to benefit from initial nephrectomy.High CRP values predict poor survival in patients with penile cancer.Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer.Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized MedicineDevelopment of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis.Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999-2004 and 2005-2008.Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer.Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy.The Prostate Cancer Patient Had Higher C-Reactive Protein Than BPH Patient.The impact of perioperative blood transfusion on survival outcomes in radical cystectomy patients.Neutrophil-lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysisPrediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8 T cells
P2860
Q33275999-5FE7A6B0-541C-4FCB-881A-538A26770562Q33591811-D58D9CB0-7573-444A-9760-BB8B68BC914DQ34363007-FDAE9609-681B-43CD-96B6-201E67B6606AQ34705218-63172906-171F-403F-AE30-5E9FFCCF92F7Q35654119-C630F72D-32E7-49CD-AD85-BF013B81F276Q35723745-ACED8E8F-539F-454A-A187-DD23CB506A4FQ36052700-E9F7EC50-8F63-4142-B9DE-FE4A128904D9Q36287943-3B090B80-E96A-4B16-B213-EB60C9876AA9Q36416423-1B4A50EA-E421-4708-A40B-5C3207330FE5Q37536769-B66BAC23-E5D4-4F8F-ADF0-DC8835EDDA0DQ37613206-B8C6C3E6-026C-485E-BCBE-134D14852DAEQ41780002-BEFD19CF-DA64-47B6-9FB5-4640D1C8EB5AQ43241453-09F85793-59FF-437B-9657-A34FCFD874FDQ49407223-E2FAA0A3-C6C0-441A-A934-E2D1CF88F343Q57074276-874E0FCD-A3D2-44EE-A0B8-3E9A736BDEF7Q58764414-70C48667-3997-4205-B3A5-831C0EB8B876
P2860
C-reactive protein as a biomarker for urological cancers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
C-reactive protein as a biomarker for urological cancers.
@en
C-reactive protein as a biomarker for urological cancers.
@nl
type
label
C-reactive protein as a biomarker for urological cancers.
@en
C-reactive protein as a biomarker for urological cancers.
@nl
prefLabel
C-reactive protein as a biomarker for urological cancers.
@en
C-reactive protein as a biomarker for urological cancers.
@nl
P2860
P356
P1476
C-reactive protein as a biomarker for urological cancers.
@en
P2093
Kazunori Kihara
Kazutaka Saito
P2860
P2888
P304
P356
10.1038/NRUROL.2011.145
P407
P577
2011-10-25T00:00:00Z